Request a visit from an Acthar Specialty Sales Consultant

If you would like to get more information about Acthar, you can request a visit from an Acthar Specialty Sales Consultant. Simply fill out the form below, and one will contact you. Please verify the information provided is correct in the e-mail generated and click send.

All fields are required except where noted.

This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid This field is incomplete or invalid
Please accept the terms
Please accept the terms

To report a side effect/adverse drug experience or quality complaint, please call Mallinckrodt Medical Information at 1-800-778-7898.

IMPORTANT SAFETY INFORMATION

SEE More

Contraindications

  • Acthar should never be administered intravenously
  • Administration of live or live attenuated vaccines is contraindicated in patients receiving immunosuppressive doses of Acthar
  • Acthar is contraindicated where congenital infections are suspected in infants
  • Acthar is contraindicated in patients with scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex, recent surgery, history of or the presence of a peptic ulcer, congestive heart failure, uncontrolled hypertension, primary adrenocortical insufficiency, adrenocortical hyperfunction or sensitivity to proteins of porcine origins

INDICATIONS

SEE More

H.P. Acthar® Gel (repository corticotropin injection) is an adrenocorticotropic hormone (ACTH) analogue used for:

  • Treatment during an exacerbation or as maintenance therapy in selected cases of systemic dermatomyositis (polymyositis)
  • Treatment during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus
  • The treatment of symptomatic sarcoidosis
  • Adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy)